A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)

Clinical trial NCT00771251 · COMPLETED

Trial details

NCT number: NCT00771251
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2008-05-01
Primary completion: 2011-10-01
Enrollment: 311

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.